I-POINT Trademark

Trademark Overview

On Wednesday, March 20, 2002, a trademark application was filed for I-POINT with the United States Patent and Trademark Office. The USPTO has given the I-POINT trademark a serial number of 76385736. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, March 19, 2006. This trademark is owned by Respirics, Inc.. The I-POINT trademark is filed in the Medical Instrument Products category with the following description:

Inhalation drug delivery device for delivering pharmaceutical products to the respiratory tract for the management of lung disease or delivered to the respiratory tract for systemic administration
i-point

General Information

Serial Number76385736
Word MarkI-POINT
Filing DateWednesday, March 20, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, March 19, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 24, 2002

Trademark Statements

Goods and ServicesInhalation drug delivery device for delivering pharmaceutical products to the respiratory tract for the management of lung disease or delivered to the respiratory tract for systemic administration
Lining/Stippling StatementThe stippling in the drawing is for shading purposes only.
Pseudo MarkI POINT

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, April 1, 2002
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRespirics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27617
Party NameRespirics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27617

Trademark Events

Event DateEvent Description
Wednesday, May 24, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, May 24, 2006ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 17, 2005EXTENSION 5 GRANTED
Wednesday, August 10, 2005EXTENSION 5 FILED
Wednesday, August 10, 2005TEAS EXTENSION RECEIVED
Thursday, July 14, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 24, 2005EXTENSION 4 GRANTED
Tuesday, February 8, 2005EXTENSION 4 FILED
Tuesday, February 8, 2005TEAS EXTENSION RECEIVED
Wednesday, September 15, 2004EXTENSION 3 GRANTED
Tuesday, August 24, 2004EXTENSION 3 FILED
Tuesday, August 24, 2004TEAS EXTENSION RECEIVED
Wednesday, August 25, 2004CASE FILE IN TICRS
Wednesday, August 4, 2004EXTENSION 2 GRANTED
Thursday, March 18, 2004EXTENSION 2 FILED
Wednesday, August 4, 2004PETITION TO REVIVE-GRANTED
Thursday, April 1, 2004PETITION TO REVIVE-RECEIVED
Thursday, May 27, 2004ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 1, 2004PAPER RECEIVED
Friday, October 31, 2003EXTENSION 1 GRANTED
Friday, August 29, 2003EXTENSION 1 FILED
Friday, August 29, 2003PAPER RECEIVED
Thursday, June 26, 2003PAPER RECEIVED
Tuesday, May 27, 2003PAPER RECEIVED
Monday, May 5, 2003PAPER RECEIVED
Thursday, April 24, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 18, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2002PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2002NOTICE OF PUBLICATION
Monday, October 21, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 3, 2002EXAMINERS AMENDMENT MAILED
Wednesday, October 2, 2002ASSIGNED TO EXAMINER
Tuesday, September 17, 2002SEC. 1(A) CLAIM DELETED
Thursday, August 22, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 22, 2002PAPER RECEIVED
Friday, August 2, 2002TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 19, 2002NON-FINAL ACTION MAILED
Tuesday, July 16, 2002ASSIGNED TO EXAMINER

Related Keywords

point tract respiratory disease lung delivered systemic administration management drug delivering